Sections

Home | Cancers | Breast Cancer

Breast Cancer

Frequency of Breast Cancer Screening is Best Guided by Both Risk, Breast Density, Says Study

Researchers Recommend Screening Every Three Years For Average-Risk Women, Every Year For Others ...

Breast cancer: MRI offers 100% screening certainty

Austria leads the World in access to Magnetic Resonance Imaging ...

Suppressing the spread of breast cancer

A Massey University cancer project has been awarded just under $200,000 to study a protein that may suppress the spread of breast cancer to other parts of the body. ... Full story

8 things women should know about breast cancer

White and black women in Los Angeles County are the most likely to be diagnosed with breast cancer, but Asians are slowly catching up ... Full story

Two New Drugs Show Promise for Patients with Aggressive Breast Cancer

Results from I-SPY 2 Study May Lead to Smaller, Faster and More Focused Phase 3 Trials of New Therapies for Patients with Triple-Negative and HER2-Positive Breast Cancer ... Full story

Insurance, distance to care can be barriers to breast reconstruction

Researchers say breast reconstruction can help with self-esteem, sexuality and body image after cancer treatment. But a UNC Lineberger study led by Michelle Roughton, MD, has found that the type of insurance a woman has as well as distance to a plastic surgeon's office can be barriers to the procedure. ... Full story

Uncovering a new principle in chemotherapy resistance in breast cancer

A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes. The findings, reported by Andre Nussenzweig, Ph.D., and Shyam Sharan, Ph.D., at the National Cancer Institute (NCI), part of the National Institutes of Health, and colleagues, appeared July 21, 2016, in Nature. ... Full story

Emory, Metaclipse Therapeutics receive NIH grant to develop breast cancer vaccine

A research team from Emory University and Metaclipse Therapeutics Corp. is developing a new cancer vaccine immunotherapy targeting triple-negative breast cancer (TNBC). This aggressive type of breast cancer is very difficult to treat because it presents a variety of gene mutations both within each tumor and among different individuals, and thus presents no defined targets for drugs or vaccines to attack. TNBC is more common among young, African-American women, and five-year survival rates are lower than for other types of breast cancers. ... Full story

Penn Preclinical Study Outlines Cardiovascular Side Effects of Breast Cancer Drug

PHILADELPHIA – A receptor protein that is the target of the breast cancer drug trastuzumab (Herceptin) is needed for proper heart blood-vessel development, reported researchers ... Full story

Exercise Improves Memory in Breast Cancer Survivors

Self-reported memory problems in survivors linked to high stress regardless of treatment ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 757 | displaying: 1 - 10